2018
Radical treatment of primary type B aortic dissection or after thoracic endovascular aortic repair to manage disseminated intravascular coagulation
Wang L, Liu F, Guo D, Xu D, Zhou X, Hou K, Zhang W, Shi Z, Tang X, Fu W. Radical treatment of primary type B aortic dissection or after thoracic endovascular aortic repair to manage disseminated intravascular coagulation. Journal Of Thoracic Disease 2018, 10: 3808-3813. PMID: 30069381, PMCID: PMC6051806, DOI: 10.21037/jtd.2018.06.93.Peer-Reviewed Original ResearchType B aortic dissectionDisseminated intravascular coagulationB aortic dissectionEndovascular repair techniquesIntravascular coagulationFL thrombosisThoracic endovascular aortic repairClinical data of patientsStable aortic diametersEndovascular aortic repairData of patientsRepair techniquesAortic repairAortic diameterFatal complicationRadical treatmentEndovascular techniquesFollow-upClinical dataDissectionThrombosisPatientsTearsCoagulationComplications
2015
Prostate Cancer‐Associated Disseminated Intravascular Coagulation with Excessive Fibrinolysis Treated with Degarelix
Ong SY, Taverna J, Jokerst C, Enzler T, Hammode E, Rogowitz E, Green MR, Babiker HM. Prostate Cancer‐Associated Disseminated Intravascular Coagulation with Excessive Fibrinolysis Treated with Degarelix. Case Reports In Oncological Medicine 2015, 2015: 212543. PMID: 26613055, PMCID: PMC4646996, DOI: 10.1155/2015/212543.Peer-Reviewed Original ResearchDisseminated intravascular coagulationProstate cancerIntravascular coagulationExcessive fibrinolysisGonadotropin-releasing hormone receptor antagonistTherapeutic drug optionsHormone receptor antagonistLife-threatening variantDays of treatmentHemorrhagic complicationsSystemic bleedingDrug optionsReceptor antagonistPatient's coagulopathySingle injectionCoagulopathyDegarelixPatientsFibrinolysisCancerCoagulationBleedingComplicationsAntagonistHypofibrinogenemia
2011
Coagulation, Bleeding, and Blood Transfusion
Miller B, Hendrickson J. Coagulation, Bleeding, and Blood Transfusion. 2011, 224-254. DOI: 10.1002/9781444345186.ch11.Peer-Reviewed Original ResearchBlood transfusionBlood conservation techniquesAbnormalities of coagulationAvailable blood productsSickle cell diseaseAvailable laboratory testsVon Willebrand diseaseBlood group classificationsTransfusion compatibilityTransfusion therapyBlood productsCell diseasePharmacological interventionsCoagulation systemWillebrand diseaseMaturational differencesTransfusionCoagulation cascadeCell-based modelDiseaseCoagulationLaboratory testsBleedingThrombophiliaInfantsCarbon monoxide-releasing molecule-2 enhances coagulation in rabbit plasma and decreases bleeding time in clopidogrel/aspirin-treated rabbits
Nielsen V, Chawla N, Mangla D, Gomes S, Arkebauer M, Wasko K, Sadacharam K, Vosseller K. Carbon monoxide-releasing molecule-2 enhances coagulation in rabbit plasma and decreases bleeding time in clopidogrel/aspirin-treated rabbits. Blood Coagulation & Fibrinolysis 2011, 22: 756-759. PMID: 22008906, DOI: 10.1097/mbc.0b013e32834c7412.Peer-Reviewed Original ResearchConceptsEar bleeding timeBleeding timeCarbon monoxide-releasing molecule-2CORM-2Plasma in vitroPlasmatic coagulationAdministration of CORM-2Improve coagulationAdministration of clopidogrelDecreased bleeding timeEffects of CORM-2Rabbit plasmaHuman plasma in vitroCoagulation in vitroCarbon monoxide-releasing moleculesEnhancement of coagulationPreclinical investigationsProcoagulant effectRabbit modelIn vivoRabbit plasma in vitroAdministrationPre-ExposureHuman plasmaCoagulation
2010
Disseminated Intravascular Coagulation
Hossain N, Paidas M. Disseminated Intravascular Coagulation. 2010, 182-194. DOI: 10.1002/9781444328332.ch10.Peer-Reviewed Original ResearchDisseminated intravascular coagulationIntravascular coagulationEndothelial damageBlood productsAmniotic fluid embolismTransfusion of bloodAbruptio placentaeObstetric patientsHemorrhagic shockSystemic activationPrimary disorderFluid balanceIntravascular thrombiCoagulation factorsMultidisciplinary approachPregnancyPatientsObstetricsCoagulationBloodDisordersCorrect useLaboratory assaysConsequences of consumptionCoagulopathyDisseminated Intravascular Coagulopathy
Hossain N, Paidas M. Disseminated Intravascular Coagulopathy. 2010, 400-406. DOI: 10.1002/9781444316780.ch31.Peer-Reviewed Original Research
2008
Training of residents in laparoscopic tubal sterilization: Long-term failure rates
Rackow BW, Rhee MC, Taylor HS. Training of residents in laparoscopic tubal sterilization: Long-term failure rates. The European Journal Of Contraception & Reproductive Health Care 2008, 13: 148-152. PMID: 18465476, PMCID: PMC3107850, DOI: 10.1080/13625180801920180.Peer-Reviewed Original ResearchConceptsLaparoscopic tubal sterilizationLong-term failure rateTubal sterilizationBipolar coagulationGynecology residentsSterilization failure ratesTeaching clinicYale-New Haven HospitalSterilization failureFailure rateLaparoscopic surgical skillsEctopic pregnancySpontaneous abortionTraining of residentsObstetricsWomenSurgical skillsClinicResident trainingCoagulationInherent risksRiskFailureResidentsPrior studies
2003
Tissue factor pathway inhibitors as a novel approach to antithrombotic therapy.
Sajadi S, Ezekowitz MD, Dhond A, Netrebko P. Tissue factor pathway inhibitors as a novel approach to antithrombotic therapy. Drug News & Perspectives 2003, 16: 363-9. PMID: 12973447, DOI: 10.1358/dnp.2003.16.6.829308.Peer-Reviewed Original ResearchConceptsTissue factor pathway inhibitorFactor pathway inhibitorTissue factorPathway inhibitorNew antithrombotic approachComplications of atherosclerosisPathogenesis of atherosclerosisAntithrombotic therapyAntithrombotic approachEndothelial injurySystemic hemostasisNeointimal formationVascular interventionsAtherosclerotic plaquesEndothelial cellsInhibitory effectExtrinsic pathwayAtherosclerosisInhibitorsPlaquesCoagulationEarly stagesComplicationsFactorsAnticoagulants
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply